Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • Authors & Reviewers
    • Overview for authors
    • Preparing manuscripts
    • Submission checklist
    • Publication fees
    • Forms
    • Editorial policies
    • Editorial process
    • Patient-Oriented Research
    • Manuscript progress
    • Submitting a letter
    • Information for reviewers
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • Authors & Reviewers
    • Overview for authors
    • Preparing manuscripts
    • Submission checklist
    • Publication fees
    • Forms
    • Editorial policies
    • Editorial process
    • Patient-Oriented Research
    • Manuscript progress
    • Submitting a letter
    • Information for reviewers
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow CMAJ Open on Twitter
Research

Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach

Karen Tu, Lindsay Bevan, Katie Hunter, Jess Rogers, Jacqueline Young and Gihad Nesrallah
January 26, 2017 5 (1) E74-E81; DOI: https://doi.org/10.9778/cmajo.20160113
Karen Tu
Institute for Clinical Evaluative Sciences (Tu, Young), Department of Family and Community Medicine and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto; Centre for Effective Practice (Bevan); Faculty of Medicine (Hunter, Rogers), University of Toronto; Nephrology Program (Nesrallah), Humber River Hospital; Keenan Research Centre (Nesrallah), The Li Ka Shing Knowledge Institute, Toronto, Ont.
MDMSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsay Bevan
Institute for Clinical Evaluative Sciences (Tu, Young), Department of Family and Community Medicine and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto; Centre for Effective Practice (Bevan); Faculty of Medicine (Hunter, Rogers), University of Toronto; Nephrology Program (Nesrallah), Humber River Hospital; Keenan Research Centre (Nesrallah), The Li Ka Shing Knowledge Institute, Toronto, Ont.
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katie Hunter
Institute for Clinical Evaluative Sciences (Tu, Young), Department of Family and Community Medicine and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto; Centre for Effective Practice (Bevan); Faculty of Medicine (Hunter, Rogers), University of Toronto; Nephrology Program (Nesrallah), Humber River Hospital; Keenan Research Centre (Nesrallah), The Li Ka Shing Knowledge Institute, Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jess Rogers
Institute for Clinical Evaluative Sciences (Tu, Young), Department of Family and Community Medicine and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto; Centre for Effective Practice (Bevan); Faculty of Medicine (Hunter, Rogers), University of Toronto; Nephrology Program (Nesrallah), Humber River Hospital; Keenan Research Centre (Nesrallah), The Li Ka Shing Knowledge Institute, Toronto, Ont.
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Young
Institute for Clinical Evaluative Sciences (Tu, Young), Department of Family and Community Medicine and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto; Centre for Effective Practice (Bevan); Faculty of Medicine (Hunter, Rogers), University of Toronto; Nephrology Program (Nesrallah), Humber River Hospital; Keenan Research Centre (Nesrallah), The Li Ka Shing Knowledge Institute, Toronto, Ont.
BCMPHMSA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gihad Nesrallah
Institute for Clinical Evaluative Sciences (Tu, Young), Department of Family and Community Medicine and Institute of Health Policy, Management and Evaluation (Tu), University of Toronto; Centre for Effective Practice (Bevan); Faculty of Medicine (Hunter, Rogers), University of Toronto; Nephrology Program (Nesrallah), Humber River Hospital; Keenan Research Centre (Nesrallah), The Li Ka Shing Knowledge Institute, Toronto, Ont.
MDMSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • In search of a comprehensive set of quality indicators for CKD care
    Kirsten P.J. Smits
    Posted on: 16 May 2017
  • Posted on: (16 May 2017)
    Page navigation anchor for In search of a comprehensive set of quality indicators for CKD care
    In search of a comprehensive set of quality indicators for CKD care
    • Kirsten P.J. Smits, PhD candidate
    • Other Contributors:

    Tu and colleagues present a set of 17 quality indicators for chronic kidney disease (CKD) in primary care. This set includes one indicator on prevalence/incidence, four on diagnosis/screening, and 12 on management/referral of CKD patients. The set was developed in a structured process, including literature research and a consensus method. This is considered the best method for developing quality indicators [1], and gives...

    Show More

    Tu and colleagues present a set of 17 quality indicators for chronic kidney disease (CKD) in primary care. This set includes one indicator on prevalence/incidence, four on diagnosis/screening, and 12 on management/referral of CKD patients. The set was developed in a structured process, including literature research and a consensus method. This is considered the best method for developing quality indicators [1], and gives the indicators face and content validity. Furthermore, they tested the feasibility of applying the indicators to routinely collected data, showing their operational validity for the Canadian primary care setting. It is relevant to establish whether their set could be useful for other countries and settings. In their discussion, Tu and colleagues mention that their set is similar to a US-based set of measures [2] and also overlapping with a Japanese-based set of measures [3]. All three sets include mainly process measures focusing on actions which are within the health care provider's control. In a recent systematic review of process quality indicators for CKD care [4], we identified 273 indicators focusing on aspects of monitoring, prescribing, drug safety, adherence and referral. Ten of these indicators had shown content, face and operational validity in at least one study. Of these ten indicators, five -that were conceptually similar- are in the set of Tu and colleagues. These include: regular monitoring of the glomerular filtration rate (eGFR), albumin-creatinin ratio (ACR), and blood pressure, prescribing of non-steroidal anti-inflammatory drugs (NSAIDs), and referral to a nephrologist for patients with poor kidney function. Other indicators were conceptually different, although sometimes related. For example, where Tu and colleagues developed an indicator on statin prescribing, others have proposed to measure monitoring of lipid levels. We propose that a comprehensive indicator set for CKD in primary care should include monitoring indicators for all relevant risk factors, that is, eGFR, ACR, blood pressure, and lipids [1]. In addition, in our opinion it is important to have a more comprehensive indicator set to evaluate the quality of pharmacological treatment in CKD patients. For this reason, we have developed and tested a set of 16 prescribing quality indicators for patients with CKD in the Netherlands, following a structured approach [5]. Four of the prescribing indicators presented by Tu and colleagues are included in this set, although some with slight variations in definitions. In addition, we developed additional indicators assessing treatment with antihypertensives, phosphate binders, and assessing medication safety [5]. Applying these indicators in primary care, we identified areas for improvement that are similar as observed by Tu and colleagues, related to underprescribing of statins, and underprescribing of ACE-i/ARB in patients with diabetes and albuminuria. In addition, we observed possible overprescribing of metformin in patients with an eGFR<30 ml/min/1.73m2, and overprescribing of combinations of NSAIDs, ACE-i/ARB and diuretics in CKD patients. We hope that quality indicator sets such as these will be implemented in quality assurance programs to identify areas for improvement in CKD care. Finally, for future use in benchmarking programs, it is important that quality indicator sets will be tested on their predictive validity for better clinical outcomes [4].

    References 1. Campbell SM, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care. 2002;11(4):358-64. 2. Litvin CB, Ornstein SM. Quality indicators for primary care: an example for chronic kidney disease. J Ambul Care Manage. 2014;37(2):171-8. 3. Fukuma S, Shimizu S, Niihata K, Sada KE, Yanagita M, Hatta T, et al. Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method. Clin Exp Nephrol. 2017;21(2):247-56. 4. Smits KP, Sidorenkov G, Bilo HJ, Bouma M, Navis GJ, Denig P. Process quality indicators for chronic kidney disease risk management: a systematic literature review. Int J Clin Pract. 2016;70(10):861-9. 5. Smits KP, Sidorenkov G, Bilo HJ, Bouma M, van Ittersum FJ, Voorham J, et al. Development and initial validation of prescribing quality indicators for patients with chronic kidney disease. Nephrol Dial Transplant. 2016;31(11):1876-86.

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

CMAJ Open: 5 (1)
Vol. 5, Issue 1
1 Jan 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach
Karen Tu, Lindsay Bevan, Katie Hunter, Jess Rogers, Jacqueline Young, Gihad Nesrallah
Jan 2017, 5 (1) E74-E81; DOI: 10.9778/cmajo.20160113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach
Karen Tu, Lindsay Bevan, Katie Hunter, Jess Rogers, Jacqueline Young, Gihad Nesrallah
Jan 2017, 5 (1) E74-E81; DOI: 10.9778/cmajo.20160113
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Trends in Quality of Care for Patients with CKD in the United States
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Evidence-based Medicine
      • Diagnostic tests
    • Nephrology
  • Nonclinical
    • Epidemiology
      • Screening tests

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Preparing manuscripts
  • Manuscript Submission Checklist
  • Publication Fees
  • Forms
  • Editorial Policies
  • Editorial Process
  • Patient-Oriented Research
  • Submit a manuscript
  • Manuscript Progress
  • Submitting a letter
  • Information for Reviewers

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Advertising
  • Media
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire